Dr. Chris Roberts AO
Non-Executive Director, Chair of the Risk, Compliance and Sustainability Committee and Member of the Audit Committee
B.Eng (Honours), MBA, PhD
Appointed a director of Sigma Healthcare Limited in October 2023. Dr. Roberts has more than 40 years’ experience in the medical device industry, including as the former CEO of Cochlear Limited (ASX:COH) from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. Mr Roberts is currently a Non-Executive Director of: HMC Capital Limited (ASX: HMC), HealthCo Healthcare and Wellness REIT (ASX: HCW), Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.